This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitè De Genève. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Paul Lambert: Innovator in Anti-Mycobacterial Vaccines
Introduction
Paul Lambert is a notable inventor based in Versoix, Switzerland. He has made significant contributions to the field of medical research, particularly in the development of vaccines. His innovative work focuses on combating mycobacterial infections, which pose serious health risks globally.
Latest Patents
Paul Lambert holds 1 patent for his invention related to anti-mycobacterial vaccines. The patent describes genetically modified arenaviruses that are suitable as vaccines against mycobacterial infections. Additionally, it encompasses pharmaceutical compositions and methods aimed at the prevention and treatment of these infections. This groundbreaking work has the potential to improve health outcomes for individuals affected by mycobacterial diseases.
Career Highlights
Paul Lambert is affiliated with the Université de Genève, where he conducts his research and development activities. His role at this prestigious institution allows him to collaborate with other experts in the field and contribute to advancements in vaccine technology.
Collaborations
Paul has worked alongside talented colleagues, including Elodie Anne Françoise Belnoue and Stéphanie Gabrielle Darbre Abdelrahman. Their combined expertise enhances the research efforts and fosters innovation in the development of effective vaccines.
Conclusion
In summary, Paul Lambert is a dedicated inventor whose work in anti-mycobacterial vaccines represents a significant advancement in medical science. His contributions are vital in the ongoing fight against mycobacterial infections, showcasing the importance of innovation in healthcare.